| Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness AK Ewer, AT Furmston, LJ Middleton, JJ Deeks, JP Daniels, HM Pattison, ... Health Technol Assess 16 (2), 1-184, 2012 | 197 | 2012 |
| Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and … P Auguste, A Tsertsvadze, J Pink, R Court, N McCarthy, P Sutcliffe, ... BMC infectious diseases 17, 1-13, 2017 | 145 | 2017 |
| Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis TE Roberts, PM Barton, PE Auguste, LJ Middleton, AT Furmston, AK Ewer Archives of disease in childhood 97 (3), 221-226, 2012 | 133 | 2012 |
| Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic … CL Althaus, KME Turner, CH Mercer, P Auguste, TE Roberts, G Bell, ... Health technology assessment (Winchester, England) 18 (2), 1-viii, 2014 | 129 | 2014 |
| Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation P Royle, H Mistry, P Auguste, D Shyangdan, K Freeman, N Lois, N Waugh Health Technology Assessment 19 (51), 1-248, 2015 | 93 | 2015 |
| Evaluating PET‐CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation C Meads, C Davenport, S Małysiak, M Kowalska, A Zapalska, P Guest, ... BJOG: An International Journal of Obstetrics & Gynaecology 121 (4), 398-407, 2014 | 59 | 2014 |
| Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high … P Auguste, A Tsertsvadze, J Pink, F Seedat, T Gurung, K Freeman, ... Health Technology Assessment (Winchester, England) 20 (38), 1-678, 2016 | 51 | 2016 |
| An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence P Auguste, P Barton, C Hyde, TE Roberts NIHR Health Technology Assessment programme: Executive Summaries, 2011 | 50 | 2011 |
| Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective … C Meads, P Auguste, C Davenport, S Małysiak, S Sundar, M Kowalska, ... Health technology assessment (Winchester, England) 17 (12), 1, 2013 | 48 | 2013 |
| Evaluating PET–CT in routine surveillance and follow‐up after treatment for cervical cancer: a cost‐effectiveness analysis P Auguste, P Barton, C Meads, C Davenport, S Małysiak, M Kowalska, ... BJOG: An International Journal of Obstetrics & Gynaecology 121 (4), 464-476, 2014 | 44 | 2014 |
| Valuing the health states associated with Chlamydia trachomatis infections and their sequelae: a systematic review of economic evaluations and primary studies LJ Jackson, P Auguste, N Low, TE Roberts Value in Health 17 (1), 116-130, 2014 | 40 | 2014 |
| Short-and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled … X Armoiry, A Kan, GJ Melendez-Torres, R Court, P Sutcliffe, P Auguste, ... Journal of Neurology 265, 999-1009, 2018 | 37 | 2018 |
| Court, R.; McCarthy, N.; Sutcliffe, P.; Clarke, A. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that … P Auguste, A Tsertsvadze, J Pink BMC Infect. Dis 17 (1), 200, 2017 | 34 | 2017 |
| Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent … K Freeman, M Connock, P Auguste, S Taylor-Phillips, H Mistry, ... Health Technology Assessment 20 (83), 1-288, 2016 | 34 | 2016 |
| Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation GJ Melendez-Torres, P Auguste, X Armoiry, H Maheswaran, J Madan, ... Health Technology Assessment 21 (52), 1-352, 2017 | 33 | 2017 |
| Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model M Connock, P Auguste, C Dussart, J Guyotat, X Armoiry Journal of Neuro-Oncology 143, 605-611, 2019 | 29 | 2019 |
| Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including … GJ Melendez-Torres, X Armoiry, R Court, J Patterson, A Kan, P Auguste, ... BMC neurology 18, 1-17, 2018 | 25 | 2018 |
| Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy P Auguste, J Madan, A Tsertsvadze, N McCarthy, P Sutcliffe, ... The International Journal of Tuberculosis and Lung Disease 23 (11), 1178-1190, 2019 | 20 | 2019 |
| How do pharmaceutical companies model survival of cancer patients? A review of NICE single technology appraisals in 2017 D Gallacher, P Auguste, M Connock International journal of technology assessment in health care 35 (2), 160-167, 2019 | 19 | 2019 |
| A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups P Auguste, A Tsertsvadze, R Court, J Pink Tuberculosis 99, 81-91, 2016 | 19 | 2016 |
